Convert your FHIR JSON -> XML and back here. The CDA Book is sometimes listed for Kindle here and it is also SHIPPING from Amazon! See here for Errata.

Monday, October 15, 2012

HL7 Offers Free Webinar Oct 24 on Laboratory Results Interface Implementation Guide Named in MeaningfulUse Stage2


 Health Level Seven® International
For Immediate Release
                                                                               
Contact: Andrea Ribick
+1 (734) 677-7777


HL7 Offers Free Ambassador Webinar on the S&I Framework Laboratory Results Interface Implementation Guide Named in Meaningful
Use Stage 2, on October 24, 2012

          Ann Arbor, Michigan, USA – October 15, 2012 – Health Level Seven® International (HL7®), the global authority for interoperability and standards in healthcare information technology with members in 55 countries, will present a complimentary Ambassador webinar on the Standards and Interoperability (S&I) Framework’s Laboratory Results Interface Implementation Guide on Wednesday, October 24 from 12:00 pm  - 1:00 pm EDT.
          This webinar will provide a background on the development and need for the Laboratory Results Interface (LRI) Implementation Guide (IG), which was included in the Meaningful Use Stage 2 Standards and Certification Criteria for 2014. The LRI Implementation Guide is based on HL7’s Version 2.5.1 and provides guidance for electronic reporting of laboratory test to ambulatory care providers in the U.S. This guide was developed within the S&I Framework supported by the Office of the National Coordinator of Healthcare Information Technology (ONC) and balloted through HL7. This session will give an explanation of why the guide is important, its benefits, and how it can handle multiple settings of the EHR from Ambulatory, Acute Care and Public Health through the use of profiles.  The LRI IG uses profiles to further refine the IG. The refinement can occur through the use of identifers, fields or other critical items that help define the information necessary to support the EHR and the Laboratory based on business requirements and the healthcare setting. In addition, this flexibility allows implementers to expand their use of the guide as they gain more functionality in their systems through the selection of more complex profiles.
The webinar will be presented by Ken McCaslin, Director of Healthcare Standards at Quest Diagnostics. Mr. McCaslin is an HL7 Fellow and Ambassador and serves as the co-chair of the HL7 Orders and Observations Work Group. In addition, he is also the co-chair of the S&I Framework LRI and LOI (Laboratory Order Interface) Implementation Guide Work Groups.
          This webinar is free and open to anyone interested in healthcare IT or standards development. To register for this free webinar, please visit http://www.hl7.org/events/ambassador20121024/.
HL7 Ambassadors present standardized presentations about HL7 as speaker volunteers. They are available to present at local, regional or national conferences. Please contact HL7 at +1 (734) 677-7777 if you would like to schedule an HL7 Ambassador for an upcoming event.


About Health Level Seven International (HL7)
Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a non-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7’s more than 2,300 members represent approximately 700 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.

HL7’s endeavors are sponsored, in part, by the support of its benefactors: Abbott; Accenture; Centers for Disease Control and Prevention; Duke Translational Medicine Institute; Epic; European Medicines Agency; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technology; Microsoft Corporation; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; Quest Diagnostics Inc.; Siemens Healthcare; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.

Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Austria, Brazil, Canada, Colombia, Croatia, Czech Republic, Finland, Germany, Greece, Hong Kong, India, Italy, Japan, Korea, Luxembourg, The Netherlands, New Zealand, Norway, Romania, Russia, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, and Uruguay.

For more information, please visit: www.HL7.org

# # #

1 comment: